Skip to main content
. 2019 Apr 18;18:2325958219841908. doi: 10.1177/2325958219841908

Table 1.

Demographic Characteristics of the Study Participants.a

Variables n (%) Patients on LPV/r, n (%) Patients on ATV/r, n (%)
Age-group, years
 21-30 13 (4.3) 7 (4.7) 6 (4.0)
 31-40 73 (24.3) 37 (24.7) 36 (24.0)
 41-50 116 (38.7) 62 (41.3) 54 (36.0)
 50 + 98 (32.7) 44 (29.3) 54 (36.0)
Sex
 Male 82 (27.3) 40 (26.7) 42 (28.0)
 Female 218 (72.7) 110 (73.3) 108 (72)
Education level
 No formal education 10 (3.3) 0 (0) 10 (6.7)
 Primary education 212 (70.7) 118 (78.7) 94 (62.7)
 Secondary education 64 (21.3) 28 (18.7) 36 (24.0)
 College/university 14 (4.7) 4 (2.7) 10 (6.7)
Marital status
 Single 44 (14.7) 22 (14.7) 22 (14.7)
 Married 166 (55.3) 89 (59.3) 77 (51.3)
 Separated 6 (2.0) 4 (2.7) 2 (1.3)
 Divorced 22 (7.3) 8 (5.3) 14 (9.3)
 Widow/widower 62 (20.7) 27 (18.0) 35 (23.3)
Occupation
 Peasant 7 (2.3) 1 (0.7) 6 (4.0)
 Unemployed 13 (4.3) 5 (3.3) 8 (5.3)
 Self-employed 212 (70.7) 102 (68.0) 110 (73.3)
 Employed 50 (16.7) 32 (21.3) 18 (12.0)
 Others 18 (6.0) 10 (6.7) 8 (5.3)
Alcohol drinkers 56 (18.7) 19 (12.7) 37 (24.7)
Cigarette smokers 8 (2.7) 2 (1.3) 6 (4.0)
Diabetes mellitus 8 (2.7) 2 (1.3) 6 (4.0)
Hypertension 2 (0.7) 2 (1.3) 0
BMI, kg/m2
 <18.50 30 (10.0) 13 (8.7) 17 (11.3)
 18.50-24.99 30 (10.0) 81 (54.0) 60 (40.0)
 25.00-29.99 69 (23.0) 36 (24.0) 33 (22.0)
 ≥30 60 (20.0) 20 (13.3) 40 (26.7)
Waist circumference 221 (73.7) 114 (76.0) 107 (71.3)
 Male ≥ 94 cm 32 (10.0) 18 (12.0) 14 (9.3)
 Female ≥ 81 cm 189 (63.00) 96 (64.0) 93 (62.0)

Abbreviations: ATV/r, atazanavir boosted with ritonavir; BMI, body mass index; LPV/r, lopinavir boosted with ritonavir.

an = 300.